Dexamethasone reduces death risks by a third in serious coronavirus cases

Researchers led by a team from the University of Oxford administered the widely available drug to more than 2,000 severely ill COVID-19 patients

Researchers led by a team from the University of Oxford administered the widely available drug to more than 2,000 severely ill COVID-19 patients